D03.10

Clinical Causes: Prolonged exposure to ultraviolet (UV) radiation from sunlight or tanning beds. Genetic predisposition, including family history of melanoma. Presence of atypical moles or skin lesions around the eye area. Fair skin, light hair, and light eye color increasing susceptibility. Weakened immune system, which may reduce the body's ability to fight abnormal cell growth.

Key Symptoms: A new or changing pigmented lesion or mole on the eyelid or surrounding area. Asymmetrical shape of the lesion with irregular borders. Variation in color within the same lesion, including shades of brown, black, or even pink and white areas. Lesion that is larger than 6mm in diameter, roughly the size of a pencil eraser. Itchiness, bleeding, or ulceration of the lesion, though these are less common in melanoma in situ.

Diagnosis Path: Diagnosis of melanoma in situ involves a thorough physical examination of the eyelid and surrounding skin, focusing on any suspicious pigmented lesions. Dermatologists may perform dermoscopy, a special imaging technique that helps evaluate skin structures. A biopsy is definitive; a sample of the lesion is removed and examined microscopically to confirm the presence of melanoma cells confined to the epidermis. Additional imaging or tests are rarely needed unless there is concern about invasive disease or spread.

Treatment Protocols: The primary treatment for melanoma in situ of the eyelid is surgical removal. Techniques include traditional excision with appropriate margins to ensure complete removal of the abnormal cells. In some cases, Mohs micrographic surgery may be employed, particularly to conserve as much healthy tissue as possible given the eyelid's anatomy. Follow-up care involves regular skin examinations to monitor for recurrence or new lesions. If the lesion is extensive or located near critical structures, additional treatments such as cryotherapy or topical medications might be considered under specialist guidance. Early detection and removal significantly improve prognosis and reduce the risk of progression to invasive melanoma.